Keros Therapeutics Reports Third Quarter 2025 Financial Results

Go back to Keros Therapeutics Reports Third Quarter 2025 Financial Results
(NASDAQ: KROS) Delayed: 11.03 +0.08 (0.73%)
Previous Close $10.95    52 Week High
Open $10.96    52 Week Low
Day High $11.09    P/E N/A 
Day Low $10.81    EPS
Volume 157,507